Long‐term follow‐up of a racially and ethnically diverse population of men with localized prostate cancer who did not undergo initial active treatment

There is limited research on the racial/ethnic differences in long‐term outcomes for men with untreated, localized prostate cancer.

[1]  J. Brooks,et al.  Undertreatment of High-Risk Localized Prostate Cancer in the California Latino Population. , 2018, Journal of the National Comprehensive Cancer Network : JNCCN.

[2]  Kathleen A Cronin,et al.  Annual Report to the Nation on the Status of Cancer, part I: National cancer statistics , 2018, Cancer.

[3]  Jong Y. Park,et al.  African‐American men and prostate cancer‐specific mortality: a competing risk analysis of a large institutional cohort, 1989–2015 , 2018, Cancer medicine.

[4]  K. Ballman,et al.  National trends in management of localized prostate cancer: A population based analysis 2004‐2013 , 2018, The Prostate.

[5]  J. King,et al.  Stage-specific incidence rates and trends of prostate cancer by age, race, and ethnicity, United States, 2004-2014. , 2018, Annals of epidemiology.

[6]  Ronald C. Chen,et al.  Clinically Localized Prostate Cancer: AUA/ASTRO/SUO Guideline. Part I: Risk Stratification, Shared Decision Making, and Care Options , 2017, The Journal of urology.

[7]  M. Terris,et al.  Race and risk of metastases and survival after radical prostatectomy: Results from the SEARCH database , 2017, Cancer.

[8]  M. Cooperberg,et al.  Association Between Radiation Therapy, Surgery, or Observation for Localized Prostate Cancer and Patient-Reported Outcomes After 3 Years , 2017, JAMA.

[9]  Mufaddal Mamawala,et al.  Intermediate and Longer-Term Outcomes From a Prospective Active-Surveillance Program for Favorable-Risk Prostate Cancer. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[10]  D. Schwartz,et al.  A Population-Based Study of Men With Low-Volume Low-Risk Prostate Cancer: Does African-American Race Predict for More Aggressive Disease? , 2015, Clinical genitourinary cancer.

[11]  A. Partin,et al.  Racial disparities in oncologic outcomes after radical prostatectomy: long-term follow-up. , 2014, Urology.

[12]  E. Castle,et al.  Racial disparities in survival for patients with clinically localized prostate cancer adjusted for treatment effects. , 2014, Mayo Clinic proceedings.

[13]  H. Parnes,et al.  Mortality and complications after prostate biopsy in the Prostate, Lung, Colorectal and Ovarian Cancer Screening (PLCO) trial , 2014, BJU international.

[14]  J. Concato,et al.  'Race' and prostate cancer mortality in equal-access healthcare systems. , 2013, The American journal of medicine.

[15]  R. V. D. van den Bergh,et al.  Outcomes of initially expectantly managed patients with low or intermediate risk screen‐detected localized prostate cancer , 2012, BJU international.

[16]  Yongmei Chen,et al.  Prostate cancer in Asian Americans: incidence, management and outcomes in an equal access healthcare system , 2011, BJU international.

[17]  John D. Roberts,et al.  Do African American Men Have Lower Survival From Prostate Cancer Compared With White Men? A Meta-analysis , 2010, American journal of men's health.

[18]  M. Cooperberg,et al.  Risk assessment for prostate cancer metastasis and mortality at the time of diagnosis. , 2009, Journal of the National Cancer Institute.

[19]  Xianglin L. Du,et al.  Impact of androgen deprivation therapy on racial/ethnic disparities in the survival of older men treated for locoregional prostate cancer. , 2009, Cancer control : journal of the Moffitt Cancer Center.

[20]  M. Symons,et al.  Racial Differences in Clinical Progression Among Medicare Recipients After Treatment for Localized Prostate Cancer (United States) , 2006, Cancer Causes & Control.

[21]  James A Hanley,et al.  20-year outcomes following conservative management of clinically localized prostate cancer. , 2005, JAMA.

[22]  H. Brenner,et al.  Long-term survival rates of patients with prostate cancer in the prostate-specific antigen screening era: population-based estimates for the year 2000 by period analysis. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[23]  Paul W Dickman,et al.  Natural history of early, localized prostate cancer. , 2004, JAMA.

[24]  J Crowley,et al.  Estimation of failure probabilities in the presence of competing risks: new representations of old estimators. , 1999, Statistics in medicine.

[25]  R. Deyo,et al.  Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. , 1992, Journal of clinical epidemiology.

[26]  Michael K Gould,et al.  Sociodemographic characteristics of members of a large, integrated health care system: comparison with US Census Bureau data. , 2012, The Permanente journal.